Anixa Biosciences files IND with FDA for ovarian cancer CAR-T therapy
Anixa Biosciences said that it has filed an investigational new drug (IND) application for its ovarian cancer CAR-T therapy with the US Food and Drug Administration (FDA). The ovarian cancer CAR-T therapy was invented by a team headed by Dr. Jose Conejo-Garcia, who is presently Chair of the Department of Immunology at Moffitt Cancer Center […]